chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information was received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. On or about 23-JAN-2015, the patient was vaccinated at a   physician office with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster, also known as shingles. On or about 11-JUL-2015, the patient was treated for  blistering vesicular outbreaks that were diagnosed as severe herpes zoster, or shingles. The patient has been prescribed VALTREX for management of his painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Pt complains of muscle pain/soreness in area of left deltoid pt has not see dr-treating with OTC Ibuprofen- (some help)
4:00 parent called & stated pt was crying & only stopped when mom held;that rt leg was red around inj site & very warm to touch;called MD who recommended APAP & cont cold compress to leg
6 days after vaccine child started getting blisters on thighs, then spread to rest of body.  No fever before outbreak.  Sister with kids in her class with chickenpox.  Physician Asst. gave antihistamine.
I noticed Rash started 4ish days later it continued to spread and on my right forearm it is angry! It seems to have colonized there.  It went away everywhere else, terrible and itchy. I?ve bought every cream I can find- will not go away!
This spontaneous report as received from a pharmacist refers to a 98 years old female patient with no pertinent medical history and no drug reactions/allergies. The patient was vaccinated SC with a 0.65 ml dose of ZOSTAVAX on 19-JUL-2012. No other co-suspects were reported. There was no concomitant medication. The pharmacist reported that on 31-JUL-2012 ("last night") the patient developed burning and pain at the injection site after receiving ZOSTAVAX. The patient contacted the pharmacist for medical attention. ALEVE was given for treatment. No lab diagnostics studies were performed. The outcome of burning and pain at the injection site was reported as not recovered/not resolved. Additional information is not expected.
Narrative: COVID infection following COVID vaccine series 01/08, Pfizer, dose #1 01/29, Pfizer, dose #2 12/28 COVID swab, result: detected 12/26 pt cc: cough, fatigue, body aches, low grade fever, sore throat, and coughing exposure: unknown 12/28 pt admit ED cc: body aches, low grade fever, sore throat, and coughing dx: COVID19 LOS: 1 day 12/31 clinically resolved
This spontaneous case, initially received from other health professional on 03-Oct-2018, concerns a 30-year-old, adult female patient. The patient had no relevant medical history. The patient had not received any concomitant medications. On 29-Sep-2018, the patient was administered influenza vaccine, (dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number, expiry date, trade name and manufacturer: not reported). On 01-Oct-2018, 2 days after vaccination (reported as Monday), the patient felt tenderness on lymph node, underneath her right arm. On 02-Oct-2018 (reported as yesterday), the tenderness had increased when she got back from work and patient was uncomfortable. It was reported that, the patient also developed tenderness of lymph node on her neck. On 03-Oct-2018 (reported as today) the patient could not go to work. At the time of this report, the patient had not recovered from the events (reported as ongoing). The reporter assessed this case as non-serious.
Admit originally for intracranial hemorrhage and pna. Found to be COVID + after admit. Fully vaccinated. COVID pna with possible aspiration pna as well. Was on RA to start but did eventually require O2 by NC. Started on steroids, cefepime, merrem, zinc, vit-D, singulair. Palliative care following. D/C to inpatient hospice.
severe headache, hot, flush, nausea. patient took own ibuprofen from purse
Mild pain at injection site & mild fatigue occurred within the 15 minute monitoring period following  administration of dose (second dose)
I had usual aches and pains, I had extreme neck pain and I felt like someone kicked me in the back of the head. My head and neck and mouth and face were in excruciating pain.
Patient felt an allergic reaction coming on in the evening after the shot. Throat was itching, hacking cough, mild fever, diarrhea Went to ER on 7/8/19 and was prescribed prednisone 40 mg x 5 days and OTC Pepcid 20 mg.
Patient states his neck feels like his whiplash is back after 5 years. States neck feels tender to touch.
Woke up on 3/23/21 with midline pain over sternum/heart area. Shortness of breath. Had telehealth appointment as no other doctor would see me in person due to having chest pain and SOB (COVID restrictions). Urgent care doctor told me to go to ER. No covid test was done, I had recovered from COVID in Nov 2020. Went to ER in evening to be seen by a doctor. Normal EKG, chest X-ray, and lab. They did not ask me about recent vaccine acquired. They didn?t really know what to diagnose me and I recall them settling on costocondritis or something similar since my pain was worse on exertion.
I experienced a rapid heartbeat; high fever; felt horrible; This case was reported by a consumer via call center representative and described the occurrence of heart rate increased in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced heart rate increased, fever and feels awful. On an unknown date, the outcome of the heart rate increased, fever and feels awful were unknown.   It was unknown if the reporter considered the heart rate increased, fever and feels awful to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. The age group was captured as an adult as per vaccine indication. The patient wanted to know whether should he/she get the second dose, when experienced a rapid heartbeat, high fever, and felt horrible after the first dose.
In 2/00, complained of joint pains in both knees and surrounding tissue to include area of 8" above and below knees. Also, pain and tingling sensation in both ankles and heels. In 12/00, pain in joints spread to elbows, wrists, hands and became progressively worse. On 4/16/01 was given Rx for Celebrex 200mg QD.
Initial report received on 12 March 2008 from the patient's parent.  A 17-year-old male patient, with no illness at the time of vaccination, had received a first dose, left deltoid, intramuscular injection of Menomune, lot number UP157AB, on 10 March 2008.  Approximately 24 hours post-vaccination, the patient developed a fever of 100 degrees Fahrenheit and body aches.  At the time of this report, the patient had not recovered.  Follow-up information received on 26 September 2008 from a health care provider.  Per the reporter, there is no complete description of the event as the patient was not seen by their facility or physicians, and no tests or treatments were provided.  The patient has not been evaluated by this physician's office since 10 September 2007.  Per the reporter, there is no additional information, and the reporter requested the case be closed.  No further information is expected.
Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness). At the time of the report, PAIN IN EXTREMITY (Arm soreness) had not resolved. Not Provided          No concomitant medications were reported.  No treatment information was reported.    Reporter did not allow further contact
"Received Moderna covid 19 imm 2 weeks ago today, this was #1 imm. -was sore afterwards for 1-2 days, this resolved  Day 8, arm was itchy and sore where injection was On day 10-11 saw a rash, then resolved day 12-13 along with soreness that resolved  Today, day 14, itchy again and seeing red blotchy spot and other patchy redness -not bumpy, not draining -no pain -nothings draining -not warm per se -not taking anything for rash itself -only taking ibuprofen prn as she does get stress HA"
I developed sensations of extreme itchiness all over, especially my upper body. My other symptom is severe fog brain, difficulty concentrating, inability to focus. Fog brain comes and goes, but was very strong on 10/03, 10/15, and today 10/19.
Sore arm, sore muscles, nausea, shivers, slight fever - like 98.5 - 99 degrees (i usually run around 97,1-97.5)
tested positive for COVID-19 three days; This is a spontaneous report from a contactable pharmacist.  A patient of unspecified age and gen-der received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine), dose 1 via an unspecified route of ad-ministration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunization.The patient's medical history and concomitant medications were not reported. The patient took Dose 1 but tested positive for COVID-19 three days after getting the shot. Caller is asking about the patient's eligibility for the Dose 2 and about the dosing interval that is beyond the 3 weeks recommended.The patient underwent lab tests and procedures which included sars-cov-1 test: positive on unspecified date. The outcome of the event was unknown.  Information on Lot/Batch has been requested.
swollen lymph node in my left armpit the size of a grapefruit; chills; nausea; headache; fever; sweating; burning/tingling in my entire arm,; fatigue; aches; burning/tingling in my entire arm,; This is a spontaneous report from a contactable consumer (patient). A 51-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 29Apr2021 (Batch/Lot Number: EW 0175) (at the age of 51 years old) as 1st dose, single for COVID-19 immunisation. Medical history included migraines from an unknown date and unknown if ongoing, and COVID in Mar2020 (including long haul effects such as loss of smell for 6 months and losing handfuls of hair). The patient's concomitant medications were not reported. It was reported that patient had COVID in Mar2020. She tested positive for antibodies in Apr2020. Upon receiving the first dose this past week, she ended up reacting just like she had COVID all over again. Within 4 hours she had chills, nausea, headache, fever, sweating, burning/tingling in my entire arm, aches, fatigue, etc, then she developed a swollen lymph node in the left armpit the size of a grapefruit. Acute symptoms persisted for 5 days (she was in bed the whole time) and she still have the swollen lymph node. She expected some symptoms for the second shot, but not the first. She was now very concerned about getting the second dose, especially since she read studies showing she could have as much protection after one shot since she had COVID as people who didn't have COVID. Additionally, she was a smaller woman and feel like maybe the dosage was too high. She was very healthy with no comorbidities except she had COVID previously (including long haul effects such as loss of smell for 6 months and losing handfuls of hair). The events resulted in emergency room/department or urgent care. Prior to vaccination, the patient diagnosed with COVID-19. The patient has been tested for COVID-19 since the vaccination. PCR (Nasal swab) was done on 03May2021 with negative result. The outcome of events was recovering.
A massive cold sore developed on my lower lip.  I have not had a flare up like this in years. I'm concerned that because I was vaccinated to stop a virus, it is causing my cold sores to flare up?  It is unusually  painful.
Patient got a 1/2 dollar size red knot at immediate injection site about 48 hours after the injection. Redness progressed to cover bicep and tricep area and had fever, which subsided after about 48 hours. The knot at the immediate injection site lasted about 3 weeks. As of 11-10-17 there was still visible redness at the immediate injection site but no swelling. Patient did not feel bad physically.
For the first dose of the vaccine on July 14, 2021, after a week I had COVID. For the second dose of the vaccine on August 11, 2021, on August 30, 2021 at about 5am to 6am I had a very strong pain in the abdomen, I felt that I was burning inside and then the pain was so strong that I couldn't breathe anymore because the pain went up to the area of ??the lungs. I was diagnosed with an inflamed pancreas and hospitalized for 5 days.
A vaccine was given to patient without the vaccine expiration being check. Age of patient at time of event: 8 months 20 days.
worsening tinnitus; headache; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (worsening tinnitus) and HEADACHE (headache) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced TINNITUS (worsening tinnitus) and HEADACHE (headache). At the time of the report, TINNITUS (worsening tinnitus) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. Treatment medications were not reported.
Patient was sitting on the exam table with her mom in the room as I was administering the HPV vaccine. I administered the vaccine in her RT deltoid muscle and turned around to toss away my sharps in the sharps container. As I turned back around I noticed Patient falling down off the exam table from a seated position and I was bae to run and catch her before she fell and hit the counter corner/ground in the exam room. I placed her in supine position  on the exam table and she opened her eyes after about 5-10 seconds and "came to" asking what was wrong/what happened.  I had her lay down for about 15 minutes and placed a cool cloth on her forehead and took her BP which did decrease a small amount from 104/64 to 90/70. Here PAP, Dr came and made sure she was doing okay before having them leave.
Developed hives/rash from knees down on both legs, and hives/rash on upper parts of both arms.  Not at the injection site.  Rash resolved itself with the application of topical corticosteroids and benadryl.
The evening of 10/04/2012, the parents noticed that patient was lethargic, hot to the touch (103 Fahrenheit temp). Parents called the doctor, and the parents alternated giving TYLENOL and ibuprofen and the fever was reduced to 102 fahrenheit. They gave patient an ice bath and noticed what they describe as "red freckles" on his entire body except on his face. They applied cold towels to his body and an hour later his temp was back to normal, he was acting normal, and the red freckles were gone in the morning.
Given Moderna COVID Vaccine as Vaccine # 2 25 days after receiving Pfizer COVID Vaccine # 1 on 1/2/2021
Cough, trouble breathing, congestion, fever. Given an over the counter cough syrup and inhaler. Still have a little bit of a cough now but fever went away after four days.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. However, no pregnant patients were reported. On an unknown dates the patients were vaccinated with GARDASIL (lot # J007354, expiration date: 20-FEB-2016), injection (dose and route not provided). The reporter mentioned that 200 doses were given to an unknown number of patients and some of those unknown number of patients (specific number unspecified) reported at the time of vaccination that it hurt a little more then before. The patient sought medical attention - were in the office. The patients were instructed to put ice at the injection site and took TYLENOL or MOTRIN. The outcome of event was reported as recovered/resolved on an unspecified date. The relatedness between vaccination with GARDASIL and event was not reported. Additional information has been requested.
Patient received Covid-19 Pfizer vaccine on 3/26 and 4/16/21 and the Covid-19 Moderna booster dose on 11/4/21.  Patient presented to BWH on 1/24/22 after OP echo revealed interval worsening of pericardial effusion with tamponade physiology on formal TTE. Patient had an episode of positional abdominal discomfort and was diagnosed with pericarditis on 1/20/21 based on EKG and labs. Patient began on colchicine and ibuprofen for medical management with improvement in symptoms. Patient found to have diffuse ST changes consistent with pericarditis. Patient completed a course of ibuprofen with plan for outpatient cardiology re assessment.
This is a spontaneous report received from a noncontactable consumer or other non-HCP (the patient). A male patient received the 3rd (booster) dose of BNT162B2 (Comirnaty, batch/lot# unknown), single dose, for COVID-19 immunization. Medical history and concomitant medications not reported. Vaccination history included the 1st and 2nd dose of the COVID-19 vaccine (manufacturer unknown); both single dose, for immunization; reaction(s): migraine/second one gave him a 5-day migraine. The patient experienced asthenia (weakness and pain in both legs)/pain in extremity, with outcome of unknown. Additional information: Caller verified the product was the Pfizer COVID-19 vaccine booster dose. "The second one gave him a 5-day migraine." No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
I was 38 weeks at the time of my second vaccine. I experienced headaches, nausea, fever, chills and diarrhea.  these symptoms lasted one day. I started also to have contractions due to the diarrhea and the following day I went to the maternity ward.
Patient reported multiple red, tender, dime-sized areas on right arm which she noticed the morning after the injection. No accompanying sypmtoms.
The patient's left arm had a circular, raised, erythematous patch of skin approximately 5" in diameter just below the site of injection on the left arm. The area was slightly warm to the touch. The patient was treated with Tylenol and Benadryl. The patient's symptoms resolved after 3 to 4 days.
This spontaneous report as received from a certified medical assistant refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' medical history, concomitant medications and drug reactions or allergies was reported. On an unknown date in 2015, an unspecified number of patients might have been vaccinated with a dose of improperly stored VAQTA, lot # K019560, expiration date 02-JUN-2017 (route of administration, doses, dose numbers not reported). VAQTA was improperly exposed to temperatures of 90F for 24 hours on 28-MAY-2015 and 91F for 24 hours on 29-MAY-2015. No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 45-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 11-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.).    Concomitant medications were not reported.  113 Bivalent doses administered after the BUD to patients 12 and up. Breakdown of doses were as 51 doses from Lot AS7140C and 60 doses from Lot AS7148B.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-689946 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-689946:- Master case
patient presented with a roughly 4 inch in diameter rash that was hot to the touch. Patient stated that the rash was painful and that her entire right arm hurt. Patient stated that the rash began to form the night of the injection. Patient stated she was heading straight to her provider's office after leaving the pharmacy.
"pain in the arm, a tingling, but no big deal"; "pain in the arm, a tingling, but no big deal"; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY ("pain in the arm, a tingling, but no big deal") and PARAESTHESIA ("pain in the arm, a tingling, but no big deal") in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY ("pain in the arm, a tingling, but no big deal") and PARAESTHESIA ("pain in the arm, a tingling, but no big deal"). At the time of the report, PAIN IN EXTREMITY ("pain in the arm, a tingling, but no big deal") and PARAESTHESIA ("pain in the arm, a tingling, but no big deal") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications High BP Medication was  provided. Treatment information was not provided.    This case was linked to MOD-2021-389209, MOD-2021-389183 (Patient Link).
pt suffered psychiatric episode and aggressive behavior. pt walked across arena claiming "i cant breath" pt then threw herself to ground and was then placed in ems crew stretcher and secured 5x and taken to ems evaluation room. pt vitals were taken pt bp 179/91 rr 19 spo2 100% ra hr 80. pt became aggressive in ems care and would at times refuse to answer or acknowledge ems crew. pt confirmed psychiatric disorders and medications. pt confirmed HTN. Providence EMS was called and pt was trasnfered to providence ems crew.